January 23, 2025 Trump’s AI Revolution: Stargate Initiative Sparks Economic Surge
January 21, 2025 Trump’s Inauguration: Crypto Soars, Tariffs Threaten Global Trade
January 20, 2025 Economic Shifts: Chicago Fed, Tech Scrutiny, and Labor Strikes
January 4, 2025 Top High-Yield Dividend Stocks To Watch For 2025
Amazon: Evaluating AWS Growth Amid Shifting Competitive Landscape
Apple: Evaluating Growth Catalysts Amid Changing Fundamentals
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
December 21, 2024 Best AI Trading & Performance Tools
Spruce Biosciences (SPRB) stock forecast for 2025
Updated: January 24, 2025 (02:16)
Sector: HealthcareThe share price of Spruce Biosciences, Inc. (SPRB) now
50/200 Day Moving Average: $0.454 / $0.548
This figure corresponds to the Average Price over the previous 50/200 days. For Spruce Biosciences stocks, the 50-day moving average is the resistance level today.
For Spruce Biosciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Spruce Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Spruce Biosciences stock price in 2025. How much will one Spruce Biosciences share be worth in 2025? Is it worth taking profit / loss on SPRB stock now or waiting? What are analysts' forecasts for Spruce Biosciences stock?
We forecast Spruce Biosciences stock performance using neural networks based on historical data on SPRB stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Spruce Biosciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Spruce Biosciences analysts is $1.833. Today 200 Day Moving Average is the resistance level (0.548 $). 50 Day Moving Average is the resistance level (0.454 $).
Historical and forecast chart of Spruce Biosciences, Inc. stock
The chart below shows the historical price of Spruce Biosciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the SPRB stock price can be found in the table below.
The company has developed a candidate product, tildaserfont, as the first potential non-steroidal therapy for the treatment of congenital adrenal hyperplasia. Congenital adrenal hyperplasia belongs to the group of hereditary diseases. People have two adrenal glands, each located at the top of each kidney. These glands produce the hormones cortisol and aldosterone, which play an important role in the body. People with congenital hyperplasia of the adrenal cortex do not synthesize the enzyme necessary for the production of hormones.
Spruce Biosciences (SPRB) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb | 0.43 | 0.40 | 0.46 | 12.88 % |
| Mar | 0.40 | 0.35 | 0.42 | 16.09 % |
| Apr | 0.38 | 0.36 | 0.41 | 11.73 % |
| May | 0.34 | 0.32 | 0.37 | 14.03 % |
| Jun | 0.30 | 0.29 | 0.33 | 13.86 % |
| Jul | 0.29 | 0.28 | 0.31 | 11.99 % |
| Aug | 0.31 | 0.29 | 0.36 | 18.41 % |
| Sep | 0.29 | 0.26 | 0.32 | 17.13 % |
| Oct | 0.31 | 0.30 | 0.34 | 13.02 % |
| Nov | 0.33 | 0.29 | 0.35 | 15.73 % |
| Dec | 0.30 | 0.29 | 0.33 | 12.90 % |
Spruce Biosciences information and performance
2001 JUNIPERO SERRA BLVD., SUITE 640, DALY CITY, CA, US
Market capitalization of the Spruce Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of SPRB shares in the company outstanding by the market price of one share.
EBITDA of Spruce Biosciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Spruce Biosciences price target for 2025 by month
Target values for the price of one Spruce Biosciences share for Feb 2025.
In Feb, the Positive dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 12.878% volatility is expected.
Pessimistic target level: 0.40
Optimistic target level: 0.46
Target values for the price of one Spruce Biosciences share for Mar 2025.
In Mar, the Negative dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 16.091% volatility is expected.
Pessimistic target level: 0.35
Optimistic target level: 0.42
Target values for the price of one Spruce Biosciences share for Apr 2025.
In Apr, the Negative dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 11.733% volatility is expected.
Pessimistic target level: 0.36
Optimistic target level: 0.41
Target values for the price of one Spruce Biosciences share for May 2025.
In May, the Negative dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 14.033% volatility is expected.
Pessimistic target level: 0.32
Optimistic target level: 0.37
Target values for the price of one Spruce Biosciences share for Jun 2025.
In Jun, the Negative dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 13.862% volatility is expected.
Pessimistic target level: 0.29
Optimistic target level: 0.33
Target values for the price of one Spruce Biosciences share for Jul 2025.
In Jul, the Negative dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 11.989% volatility is expected.
Pessimistic target level: 0.28
Optimistic target level: 0.31
Target values for the price of one Spruce Biosciences share for Aug 2025.
In Aug, the Positive dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 18.407% volatility is expected.
Pessimistic target level: 0.29
Optimistic target level: 0.36
Target values for the price of one Spruce Biosciences share for Sep 2025.
In Sep, the Negative dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 17.132% volatility is expected.
Pessimistic target level: 0.26
Optimistic target level: 0.32
Target values for the price of one Spruce Biosciences share for Oct 2025.
In Oct, the Positive dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 13.018% volatility is expected.
Pessimistic target level: 0.30
Optimistic target level: 0.34
Target values for the price of one Spruce Biosciences share for Nov 2025.
In Nov, the Positive dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 15.733% volatility is expected.
Pessimistic target level: 0.29
Optimistic target level: 0.35
Target values for the price of one Spruce Biosciences share for Dec 2025.
In Dec, the Negative dynamics for Spruce Biosciences, Inc. shares will prevail with possible monthly volatility of 12.898% volatility is expected.
Pessimistic target level: 0.29
Optimistic target level: 0.33
